Funded Startups in Ness Ziona
In the Ness Ziona rows shown (17 total), the largest disclosed round is Enlivex Therapeutics’ $212M on 2025-11-24.
In the Ness Ziona rows shown (17 total), the largest disclosed round is Enlivex Therapeutics’ $212M on 2025-11-24. That amount dwarfs the next-largest disclosed figures of $50M (Quantum Source, 2024-09-10) and $40M (Quantum Art, 2026-04-27), while most other disclosed rounds sit far below $26M (e.g., $18M for DOT Compliance on 2024-04-15 and $14M for INNOVENTRIC on 2021-11-01).
Timing and stage also cluster in ways that stand out. Disclosed rounds span 2020-05-20 (Newsight Imaging) through 2026-04-27 (Quantum Art), and there is a heavy concentration in late 2024 and early 2025, with multiple entries in 2025 (e.g., VisIC Technologies $26M on 2025-12-10; BIOMx $3M on 2025-12-29; Scinai Immunotherapeutics $3M on 2026-04-24). Sector-wise, Biotechnology is the most common theme (appearing in 8 of 17 rows), and “Series Unknown” shows up in 5 rows, alongside one “undisclosed” amount (CardiaCare, 2022-06-07).
Most recent rounds
17 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Ness Ziona list, and how does it compare to other disclosed amounts?
Enlivex Therapeutics raised the largest disclosed amount here: $212M on 2025-11-24. It is far above the next-largest disclosed rounds of $50M (Quantum Source, 2024-09-10) and $40M (Quantum Art, 2026-04-27), with several other rounds in the single-digit millions (e.g., IBI-Ag $4M on 2025-11-16; Eye-Net Mobile $3M on 2025-12-01).
Are the most recent rounds clustered in a narrow time window, or spread evenly across years?
They’re not evenly spread. Several of the freshest entries cluster in late 2025 and early 2026, including VisIC Technologies $26M on 2025-12-10, Enlivex Therapeutics $212M on 2025-11-24, BIOMx $3M on 2025-12-29, and Quantum Art $40M on 2026-04-27, while older disclosed rounds appear as early as 2020-05-20 (Newsight Imaging, $7M).
Which sectors are over-represented among these 17 rows?
Biotechnology dominates this list with 8 of 17 rows (e.g., Enlivex Therapeutics $212M on 2025-11-24, Scinai Immunotherapeutics $3M on 2026-04-24, and DOT Compliance $18M on 2024-04-15). Other sectors appear less frequently across single-digit counts, such as Health Care (2 rows: NanoPass Technologies $4M on 2024-07-15; CardiaCare is “undisclosed” on 2022-06-07) and Hardware (1 row: Newsight Imaging $7M on 2020-05-20).
How much of the dataset is hard to classify by stage (Series Unknown or undisclosed amounts)?
Stage disclosure is incomplete: 5 of 17 rows are labeled “Series Unknown” (e.g., Scinai Immunotherapeutics on 2026-04-24; BIOMx on 2025-12-29; VisIC Technologies on 2025-12-10). In addition, one row lists an undisclosed amount (CardiaCare on 2022-06-07), which removes it from any largest/smallest comparisons based on disclosed dollars.
Are there notable outliers besides the largest round, such as unusually small disclosed amounts or unusual stage/sector pairings?
Yes. The smallest disclosed amount in these rows is $170K for Kadimastem (2025-07-17), which is orders of magnitude below the top disclosed figures (e.g., Enlivex Therapeutics $212M on 2025-11-24). On the high side within disclosed values, amounts also concentrate around mid-to-high tens of millions (e.g., Quantum Source $50M and VisIC Technologies $26M), rather than clustering tightly in the low single millions.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.